Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Contingent Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Contingent Liabilities ₹0.86 Cr₹0.55 Cr₹0.55 Cr₹0.55 Cr₹2.74 Cr

What is the latest Contingent Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Contingent Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹0.86 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹0.86 Cr
Mar2024₹0.55 Cr
Mar2023₹0.55 Cr
Mar2022₹0.55 Cr
Mar2017₹2.74 Cr

How is Contingent Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Contingent Liabilities % Change
Mar2025 ₹0.86 Cr
56.18
Mar2024 ₹0.55 Cr
0.00
Mar2023 ₹0.55 Cr
0.00
Mar2022 ₹0.55 Cr
-79.96
Mar2017 ₹2.74 Cr -

Compare Contingent Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,029.3 Cr -7.2% -14.3% -31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-7.2%

-14.3%

-31.8%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses